Citation Tools

Download PDFPDF

Extended report
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

Download to a citation manager

Cite this article as:
Keystone EC, Taylor PC, Drescher E, et al
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate